Oral EVO756 50 mg BID

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible UrticariaNCT06603220EVMNPhase 2Completed2025-05-08Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.